Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 18.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 33,061 shares of the company’s stock after selling 7,527 shares during the period. Corient Private Wealth LLC’s holdings in Option Care Health were worth $767,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Madison Investment Advisors LLC acquired a new position in shares of Option Care Health during the fourth quarter valued at $4,135,000. Connor Clark & Lunn Investment Management Ltd. grew its position in Option Care Health by 171.3% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 394,019 shares of the company’s stock valued at $9,141,000 after buying an additional 248,762 shares in the last quarter. HighTower Advisors LLC increased its stake in Option Care Health by 16.7% during the 4th quarter. HighTower Advisors LLC now owns 468,082 shares of the company’s stock valued at $10,860,000 after buying an additional 67,021 shares during the period. AlphaQuest LLC raised its position in shares of Option Care Health by 417.8% during the 4th quarter. AlphaQuest LLC now owns 23,520 shares of the company’s stock worth $546,000 after buying an additional 18,978 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its holdings in Option Care Health by 5.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 28,840 shares of the company’s stock worth $669,000 after purchasing an additional 1,509 shares in the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Shares of OPCH stock opened at $35.20 on Friday. The company has a market capitalization of $5.78 billion, a price-to-earnings ratio of 29.58, a P/E/G ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock’s fifty day simple moving average is $32.36 and its 200-day simple moving average is $28.42.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.64% of the company’s stock.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of research reports. UBS Group started coverage on Option Care Health in a research note on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. Barrington Research lifted their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. Finally, Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health currently has an average rating of “Moderate Buy” and a consensus price target of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.